NF2, moesin-ezrin-radixin like (MERLIN) tumour suppressor
Last updated 17 Apr 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The NF2 gene provides instructions for the production of a protein called merlin, also known as schwannomin. This protein is made in the nervous system, particularly in specialized cells called Schwann cells that wrap around and insulate nerves.
Video picks for GenesVideo library
Normal function
The NF2 gene provides instructions for the production of a protein called merlin, also known as schwannomin. This protein is made in the nervous system, particularly in specialized cells called Schwann cells that wrap around and insulate nerves.
Merlin helps regulate several key signaling pathways that are important for controlling cell shape, cell growth, and the attachment of cells to one another (cell adhesion). This protein functions as a tumour suppressor, preventing cells from growing and dividing too fast or in an uncontrolled way.
Conditions referring to this gene or chromosome
Other names
ACN
BANF
MERL_HUMAN
merlin
moesin-ezrin-radixin-like protein
SCH
schwannomerlin
schwannomin
Patient picks for Genes

Skin, nail and hair health
What it's really like to live with rosacea
When Lex Gillies was 21, she went to the doctor with symptoms she describes as 'unbearable'. Over the previous three years, her always-sensitive skin had become increasingly prone to flushing, and that flushing was taking longer to go down.
by Abi Millar

Cancer
Brain tumours
This leaflet aims to give a brief overview of the various types of brain tumours. The treatment and survival rates vary greatly, depending on factors such as the type of tumour and the location in the brain.
by Dr Toni Hazell, FRCGP

Bones, joints and muscles
The most likely reasons for your muscle pain
If you're always busy, rushing about and feeling stressed, it's likely to be a recipe to end up with muscle strains. The good news is there are some simple tips to keep you moving.
by Dr Sarah Jarvis

Ear, nose and throat
When it feels like something is stuck in your throat
Some patients tell me that they would sooner have constant pain than put up with swallowing difficulties. I suppose it's because long-term pain is something the brain can 'tune out' whereas a symptom that occurs in connection with an activity such as swallowing or that comes and goes is less easy to ignore. Also, whatever the cause of pain, the supermarket shelves are stuffed with tablets to help relieve it. You can't say the same about swallowing problems.
by Dr Laurence Knott

Cancer
What it's like to be a breast surgeon with breast cancer
As a consultant breast surgeon, Dr Liz O'Riordan was used to performing operations, reassuring frightened women and breaking bad news. What she wasn't so familiar with was being the patient herself.
by Natalie Healey

Digestive health
What it's like to have an invisible disability
In the UK, there are approximately 13.9 million people living with a disability. But only a small percentage have illnesses that can actually be seen. Those living with an invisible disability, like Crohn's disease or multiple sclerosis, suffer from symptoms every day and, because these aren't visible, they're often subjected to discrimination and misunderstanding when they use disabled bathrooms, parking spaces or priority seats.
by Karen Gordon
Related patient information and medicines

Patient information leaflet
Acoustic neuroma
An acoustic neuroma is a rare non-cancerous tumour in the brain. In fewer than 1 in 10 people, an acoustic neuroma is caused by neurofibromatosis type 2 (NF2). NF2 is a very rare genetic disorder that causes non-cancerous (benign) tumours of the nervous system. People with NF2 can also develop benign tumours on the sp... About 7 out of every 100.

Patient information leaflet
Breast cancer
...://patient.info/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [https://patient.info/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest:.

Patient information leaflet
Nasal polyps
Nasal polyps are fleshy swellings that grow inside the nose or sinuses. They are usually non-cancerous (benign). The most common symptoms they cause are a stuffy, runny nose. Nasal polyps often return after treatment, so steroid nasal sprays can be used daily to prevent recurrence. What do nasal pol... Nasal polyps treatment Everyone with nasal.

Patient information leaflet
Acromegaly
Acromegaly is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The cause is usually a small non-cancerous growth (tumour) in the pituitary gland. This excess hormone stimulates the growth of bones and tissues in the body, leading to an.

Patient information leaflet
Kidney cancer
If kidney cancer is diagnosed at an early stage, there is a good chance of a cure. Renal cell cancer This type of cancer develops from a cell in a kidney tubule, which becomes cancerous (malignant). The cancer grows and forms into a tumour within the kidney. As the tumour grows: The affected kidney tends to become larger. In time the tumour may.

Patient information leaflet
Melanoma skin cancer
Melanoma (also called malignant melanoma) is the most serious type of skin cancer. It can be caused by too much sun exposure, but sometimes even people who haven't had much sun get melanoma too. The treatment for melanoma is mainly surgical but other treatments, including chemotherapy and radiotherapy, are increasingly used, especially if it is.
Further reading and references
- NF2, moesin-ezrin-radixin like (MERLIN) tumour suppressor; MedlinePlus, National Library of Medicine.
- Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP. Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat. 2007 Jan;28(1):1-12. doi: 10.1002/humu.20393.
- Cooper J, Giancotti FG. Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett. 2014 Aug 19;588(16):2743-52. doi: 10.1016/j.febslet.2014.04.001. Epub 2014 Apr 12.
- Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet. 2008 Jun;45(6):332-9. doi: 10.1136/jmg.2007.056499. Epub 2008 Feb 19.
- MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr, Perry A, Louis DN. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003 Jun 24;60(12):1968-74. doi: 10.1212/01.wnl.0000070184.08740.e0.
- Petrilli AM, Fernandez-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene. 2016 Feb 4;35(5):537-48. doi: 10.1038/onc.2015.125. Epub 2015 Apr 20.
- Schroeder RD, Angelo LS, Kurzrock R. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget. 2014 Jan 15;5(1):67-77. doi: 10.18632/oncotarget.1557.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

